NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 38,400 shares, a decrease of 47.5% from the November 30th total of 73,200 shares. Based on an average daily volume of 464,500 shares, the days-to-cover ratio is presently 0.1 days.

NovaBay Pharmaceuticals Stock Up 2.3 %

Shares of NBY traded up $0.01 during trading hours on Friday, hitting $0.58. 82,719 shares of the stock were exchanged, compared to its average volume of 894,269. NovaBay Pharmaceuticals has a fifty-two week low of $0.36 and a fifty-two week high of $9.08. The stock has a market cap of $2.44 million, a PE ratio of -0.06 and a beta of 2.82.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.